Company News: Page (1) of 1 - 05/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Forty Seven, Inc. to Present Clinical Data on 5F9, its First-in-Class CD47 Antibody, at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

-- Oral Presentations Include Preliminary Data from Phase 1b/2 Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma (r/r NHL) and Data from Phase 1 Phar... (May 16, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Pro AV,Presentors,Business Issues,Presentation, Inc.,Science,Medical,Cancer,
Related Sites: Digital Producer ,   Audio Video Producer ,   Presentation Master ,   Oceania ,   DMN Newswire ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   KNews Newsletter ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- @ Copyright, 2017 Digital Media Online, All Rights Reserved